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Introduction
The most prominent findings in pseudohypoparathy-
roidism (PHP) are hypocalcemia, hyperphosphatemia,
and elevated serum concentration of parathyroid hor-
mone (PTH), which reflect end-organ resistance to the
actions of this hormone (1, 2). In PHP type Ia (PHP-Ia),
end-organ resistance is usually not limited to the PTH
actions but can also affect other hormones, such as
thyrotropin and gonadotropins (1, 2). Patients affect-
ed by PHP-Ia also have physical features of Albright
hereditary osteodystrophy (AHO), including obesity,
short stature, brachydactyly, and ectopic ossification.
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Patients with pseudohypoparathyroidism type Ib (PHP-Ib) have hypocalcemia and hyperphosphatemia
due to renal parathyroid hormone (PTH) resistance, but lack physical features of Albright hereditary
osteodystrophy. PHP-Ib is thus distinct from PHP-Ia, which is caused by mutations in the GNAS exons
encoding the G protein α subunit. However, an imprinted autosomal dominant form of PHP-Ib (AD-
PHP-Ib) has been mapped to a region of chromosome 20q13.3 containing GNAS. Furthermore, loss of
methylation at a differentially methylated region (DMR) of this locus, exon A/B, has been observed thus
far in all investigated sporadic PHP-Ib cases and the affected members of multiple AD-PHP-Ib kindreds.
We now report that affected members and obligate gene carriers of 12 unrelated AD-PHP-Ib kindreds
and four apparently sporadic PHP-Ib patients, but not healthy controls, have a heterozygous approxi-
mately 3-kb microdeletion located approximately 220 kb centromeric of GNAS exon A/B. The deleted
region, which is flanked by two direct repeats, includes three exons of STX16, the gene encoding syntax-
in-16, for which no evidence of imprinting could be found. Affected individuals carrying the microdele-
tion show loss of exon A/B methylation but no epigenetic abnormalities at other GNAS DMRs. We there-
fore postulate that this microdeletion disrupts a putative cis-acting element required for methylation at
exon A/B, and that this genetic defect underlies the renal PTH resistance in AD-PHP-Ib.
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PHP-Ia is associated with inactivating defects of the
stimulatory G protein α subunit (Gsα), which can be
detected by an approximately 50% reduction in the
level/activity of this protein in easily accessible cells
such as erythrocytes (1, 2). These defects are caused by
heterozygous mutations in one of the 13 exons of
GNAS that encode Gsα (3).
In addition to Gsα, GNAS gives rise to several other
transcripts and protein products (Figure 1a). Transcripts
encoding XLαs and NESP55 are expressed mainly in
neuroendocrine tissues and are derived from the pater-
nal or maternal GNAS allele, respectively (4–9). The A/B
(also referred to as exon 1A or 1′) and the antisense tran-
scripts, which are presumed to be untranslated, show
ubiquitous expression and are both derived from the
paternal allele (10–13). Furthermore, the promoters of
these transcripts are differentially methylated, and in
each case transcription takes place from the nonmethy-
lated promoter. In contrast, the promoter driving expres-
sion of Gsα lacks differential methylation and is biallel-
ically active in most tissues (8, 9, 14, 15). However,
through as-yet-undefined mechanisms, paternal Gsα
expression is silenced in certain cells, including the cells
of the renal proximal tubules, the pituitary gland, the
thyroid gland, and the gonads (16–19).
The same GNAS mutations resulting in inactive Gsα
mutants are also found in a variant of PHP-Ia termed
pseudo-PHP (PPHP), which is characterized by the
presence of AHO without hormone resistance (1, 2).
Patients with PHP-Ia and PPHP are typically found
within the same kindred, but not within the same sib-
ship, and it is now known that inheritance of a Gsα
mutation from a mother affected by either
PHP-Ia or PPHP leads to PHP-Ia, i.e., AHO
with hormone resistance, while inheri-
tance of the same mutation from a father
affected by either disorder leads to PPHP,
i.e., AHO without hormone resistance (20,
21). Thus, in a given PHP-Ia/PPHP kin-
dred, the type of disorder that develops in
the offspring depends on the gender of the
parent transmitting the mutation, rather
than the type of disorder in that parent
(Figure 1b). This parent-of-origin–specific
mode of inheritance in PHP-Ia/PPHP kin-
dreds is consistent with recent findings
indicating that Gsα expression occurs pre-
dominantly from the maternal allele in
some tissues or cells (16–19).
PHP-Ib is another variant of PHP in
which end-organ resistance appears to be
limited primarily to the actions of PTH in
the renal cortex, thus leading to hypocal-
cemia and hyperphosphatemia. Patients
with PHP-Ib do not present with AHO, and
GNAS mutations leading to reduced Gsα
activity have been excluded in this disorder
(1, 2). However, an autosomal dominant
form of PHP-Ib (AD-PHP-Ib) has been
genetically linked to a region on 20q13.3 that includes
GNAS (22). In addition, similar to the hormone-resist-
ance phenotype in PHP-Ia/PPHP kindreds, PTH
resistance in AD-PHP-Ib has been shown to develop
only in offspring of female obligate carriers, i.e., off-
spring inheriting the genetic defect from male obli-
gate carriers do not have PTH resistance (see Figure
1b) (22, 23). Moreover, all sporadic and familial 
PHP-Ib cases investigated thus far show a loss of
methylation at the maternal GNAS exon A/B and bial-
lelic expression of A/B transcripts (23, 24). These find-
ings suggested that AD-PHP-Ib is caused by a muta-
tion or mutations in a cis-acting element of GNAS that
controls exon A/B methylation and that the loss of
methylation at this site leads to a profound reduction
or a complete lack of Gsα expression in the renal
proximal tubules (and possibly a few other tissues),
where this signaling protein is predominantly derived
from the maternal allele (16). Recently, genetic stud-
ies and direct sequence analyses strongly suggested
that the genetic mutation responsible for the exon
A/B methylation defect and the resulting PTH resist-
ance is located more than 50 kb upstream of exon
A/B, thus implicating a long-range regulatory element
in the pathogenesis of AD-PHP-Ib (23).
Through further genetic analyses of different AD-PHP-
Ib kindreds, we have now been able to significantly reduce
the size of the critical interval and to identify within this
interval a heterozygous microdeletion that segregates
with the disease in multiple kindreds. The same
microdeletion was also found in some apparently spo-
radic PHP-Ib cases, but not in healthy unrelated controls.
Figure 1
The GNAS locus and parent-of-origin–specific inheritance of hormone resistance.
(a) GNAS gives rise, besides Gsα, to multiple other transcripts including NESP55,
XLαs, the antisense (AS) and A/B (also referred to as 1A or 1′), all of which show
differential methylation (asterisks) in their promoters and are expressed exclu-
sively from the non-methylated paternal (p) or maternal (m) allele. Exons that
lead to transcripts in the sense (right-pointing arrow) and antisense (left-point-
ing arrow) directions are depicted as black and gray boxes, respectively, and the
splice patterns are indicated. Note that the promoter giving rise to the Gsα tran-
script, encoded by exons 1 through 13, does not show differential methylation.
However, although expression is biallelic in most tissues, Gsα transcription from
the paternal GNAS allele is proposed to be silenced in a limited number of cells
(dotted arrow), including those in renal proximal tubules. (b) In kindreds with
PHP-Ia and PPHP, as well as in those with AD-PHP-Ib, the genetic defect (black
squares) leads to hormone resistance only if it is inherited from a female obligate
carrier of the GNAS mutation. On the other hand, hormone resistance does not
develop if the genetic defect is inherited from a male obligate carrier. Each black
square indicates the mutation leading to PHP-Ia/PPHP or AD-PHP-Ib. Paternal
and maternal alleles of the GNAS locus are depicted by white and gray rectangles,
respectively. X’s indicate the silencing of paternal Gsα expression that occurs in a
small number of cells, including those of the renal proximal tubules.
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Methods
Patients with PHP-Ib. Most of the investigated AD-PHP-
Ib cases were previously reported (22, 23, 25). Bio-
chemical features of the probands in the previously
noninvestigated AD-PHP-Ib families are provided in
Table 1. The study was approved by the Subcommittee
on Human Studies of Massachusetts General Hospital,
and informed consent was obtained from all subjects.
Genotype analysis. Most markers on chromosome
20q13.3 that were analyzed in this study and the con-
ditions for their amplification by PCR have been pre-
viously described (22, 23, 26). Microsatellite marker
261P9-CA1 was amplified with the following primers:
5′-ACATGTGTGTGCACCTGTCC-3′ (forward) and 5′-
GGCTTTTCTCAAAGCACCAC-3′ (reverse). The C/T sin-
gle nucleotide polymorphism (SNP) 261P9-15,686
was amplified with the following primers: 5′-
ATGTTTCCCCTTGATTGTGC-3′ (forward) and 5′-
GCCTGCCTACCTAAATCTT-3′ (reverse). MslI, whose
recognition sequence is introduced by the thymidine
nucleotide, was used to determine the parental origin
of each allele. The C allele gives rise to 664-bp and
426-bp fragments, and the T allele to 473-bp, 191-bp,
and 426-bp fragments. PCR conditions were as
described previously (23).
Detection of the 3-kb microdeletion by Southern blot analy-
sis. (The approximately 3-kb microdeletion will be
referred to hereafter as a 3-kb microdeletion.) Genom-
ic DNA was digested with AvrII or ClaI and subse-
quently separated on a 0.8% agarose gel before trans-
fer onto nitrocellulose. Blots were hybridized with
PCR-generated 32P-labeled probes corresponding to
nucleotides 2,163–3,906 and 15,213–16,303 of
AL139349, respectively. Hybridization and washing
conditions were as described previously (22).
Detection of the 3-kb microdeletion by PCR. The deleted
region was amplified with the following forward and
reverse primers: 5′-TTGGCAGATAACTGCTGTGG-3′ and
5′-CGAGGCATGGGAAGAGAATA-3′. The Expand long-
template PCR system was used with Buffer 3 (Roche
Molecular Biochemicals, Indianapolis, Indiana, USA).
Cycling conditions included one cycle of 94°C for 2 min-
utes; ten cycles of 94°C for 10 seconds, 58°C for 30 sec-
onds, and 68°C for 4 minutes; 25 cycles of 94°C for 10
seconds, 58°C for 30 seconds, and 68°C for 4 minutes,
with an additional 20 seconds at 68°C after each cycle;
and a final extension step at 68°C for 7 minutes. Based
on the location of the primers, the product correspond-
ed to nucleotides 3,606–7,951 of AL139349, thus yield-
ing a fragment of approximately 4.3 kb from the wild-
type allele and of approximately 1.3 kb from the mutant
allele. These fragments were detected by 0.7% agarose gel
electrophoresis followed by ethidium bromide staining.
Sequence analysis of the region deleted in AD-PHP-Ib and
the coding STX16 exons. Three overlapping PCRs were
used to amplify the 3-kb region from genomic DNA of
patients who lack the microdeletion. PCR was also used
to amplify individual STX16 exons from genomic DNA
of an affected individual from kindred W (W-III/12).
PCR products were directly sequenced using nested
sequencing primers as previously described (23).
Obtained sequences were compared with the sequence
of AL139349, except for the sequence from STX16 exon
1, which was compared with the sequence of AL050327.
Primer sequences are available upon request.
Methylation analysis of GNAS. To assess differential
methylation, Southern blots of genomic DNA digested
with methylation-sensitive enzymes were performed as
described (23). Alternatively, or in combination, differen-
tial methylation was assessed by direct sequence and
restriction enzymatic analyses of PCR products amplified
from bisulfite-treated genomic DNA (bisulfite PCR
analysis). Conditions for bisulfite treatment and primer
sequences for amplification of the exon A/B region were
as previously described (27). The amplicon from the lat-
ter region was sequenced directly, and also digested with
either FauI or HinfI to determine cytosine-to-thymidine
conversion. The following forward and reverse primers
were used to amplify the exon NESP55 region from bisul-
fite-treated DNA: 5′-GAGGATAAAGATTTAAGGGATTT-3′
and 5′-CTCAAACTCCCCAATTTAAC-3′ for primary PCR,
and 5′-GAAGGAGTTTAAGGAGGAGAAGTAG-3′ and 5′-
CCATAAAAACAAAAAAAATCTAAAC-3′ for nested PCR. The
amplicon was directly sequenced and also digested with
AciI. The following primers were used to amplify the exon
XL region from bisulfite-treated DNA: 5′-GGTAGTT-
Table 1
Information on index cases in previously noninvestigated AD-PHP-Ib kindreds
Kindred T2 I K H1 H2 T3 H3
Age at presentation (yr) 26 30 8 39 8 16 14
Additional affected members 3 2 3 2 0A 0A 0
PTH (pg/ml) 653 208 381 1530B 185C 247 168
(normal range) 12–72 10–55 10–55 290–850 10–65 10–65 20–65
Calcium (mmol/l) 1.95 1.14 1.41 1.80 2.10 1.10 2.03
(normal range) 2.05–2.65 2.2–2.60 2.15–2.70 2.05–2.65 2.15–2.70 2.05–2.65 2.13–2.63
Phosphate (mmol/l) 1.42 2.08 3.18 1.15 2.26 3.42 2.00
(normal range) 0.8–1.6 0.8–1.6 1.2–1.8 0.8–1.6 1.2–1.8 0.8–1.6 0.8–1.6
AMaternal DNA samples, which were available for the index cases in kindreds H2 and T3, also showed the 3-kb microdeletion, indicating that these mothers
are unaffected obligate carriers. DNA samples from the parents of the index case in kindred H3 were unavailable. BPTH was measured by a radioimmunoas-
say specific for the C-terminal portion of PTH, rather than by two-site immunometric assay as for the other cases. CNot the value at presentation, but meas-
ured after the patient had discontinued her treatment for 3 weeks.
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TATTTTAAGAGGTTGTTAGATTT-3′ and 5′-AAAAAAAT-
ACTTTTCCTCCCTCC-3′ for primary PCR, and 5′-
GGGTAGTAGTTTTTGGATGGAGAT-3′ and 5′-CATCTC-
TACTACTTCCTCCTCAACTAAA-3′ for nested PCR. The
amplicon was directly sequenced or digested with SalI.
Methylation analyses of the deleted region and STX16 pro-
moter. Bisulfite PCR analysis was used for assessment of
differential methylation at 15 CpG dinucleotides locat-
ed within STX16 exon 4. Through the use of leukocyte
genomic DNA from an affected member of kindred F (F-
IV/47) who inherited the 3-kb deletion from her moth-
er, or from an unaffected obligate carrier of the same
kindred (F-III/34) who inherited the same deletion from
her father (22), separate analysis of the paternal and
maternal alleles could be performed. The analysis was
also performed on DNA from a normal control and the
previously reported patient with paternal uniparental
isodisomy of chromosome 20q (28). The first PCR used
the following forward and reverse primers: 5′-
GATTGAGTGAATAGAGTTTTTTATTTTT-3′ and 5′-ATTC-
CAAACCAAAATTTCACATAAA-3′; the nested PCR used the
following forward and reverse primers: 5′-GTGGTAGT-
GTTAGTAGAGGGGTTTTT-3′ and 5′-AACATATTCAAAAAC-
TAACAATAAAAAATA-3′. The nested amplicon, which cor-
responded to nucleotides 4,501–4,848 of AL139349, was
sequenced directly or after subcloning into pCR4-TOPO
vector from Invitrogen Corp. (Carlsbad, California,
USA). Restriction endonucleases HinfI or AciI were also
used to digest the amplicons for assessment of bisulfite-
mediated cytosine-to-thymidine conversion. Methyla-
tion of CpG dinucleotides was also investigated in two
different regions within the CpG island spanning the
putative STX16 promoter. Analysis was performed
through the use of genomic DNA sam-
ples from a normal control and the
patient with paternal uniparental
isodisomy of chromosome 20q (28).
Primary PCR for one of these regions
used 5′-TTGTTTTAATGGATGTTTTA-
TATTAATTTT-3′ and 5′-AAACAAAAACT-
CCAAACAACCTAAC-3′ as forward and
reverse primers, respectively. Nested
PCR used 5′-GGGTTAGGTTTTTGGTTT-
TAAGTTT-3′ and 5′-AAAAATCTCTATTC-
CCTACCTAAACC-3′. The nested prod-
uct (nucleotides 108,821–109,103 of
AL050327) was either sequenced
directly or digested with either HhaI or
HpyCH4IV. Primary PCR for the sec-
ond region used 5′-TGGGGATTAT-
GTTTTTAATTTGATT-3′ and 5′-AAAAAC-
CCCAACCAAACAAC-3′ as forward and
reverse primers, respectively. Nested
PCR for the second region used 5′-
GTAGTGTGGGGATAAATTTTTTTT-3′
and 5′-AACATCCATTAAAACAAATAA-
CAAAATAC-3′. The nested product
(nucleotides 108,044–108,382 of
AL050327) was either sequenced
directly or digested with HinfI. In all reactions to ampli-
fy the bisulfite-treated DNA, HotMaster Taq from
Eppendorf North America Inc. (Westbury, New York,
USA) was used. Conditions included one cycle of 94°C
for 2 minutes; 40 cycles (primary) or 25 cycles (nested)
of 94°C for 45 seconds, 54°C for 45 seconds, and 65°C
for 2 minutes; and one cycle of 65°C for 10 minutes.
Nucleotide sequence analyses and comparisons. To identi-
fy the regions conserved in mouse and rat, “percent
identity plots” for human (AL139349-GenBank) ver-
sus mouse (ENSMUSG00000027522-Ensembl Gene
ID) or human versus rat (ENSRNOG00000005281)
genomic DNA were generated by MultiPipMaker
(http://bio.cse.psu.edu) (29); no sequences were
masked except for the dinucleotide repeat in intron 6
(261P9-CA1). Dot blots were generated by PipMaker
(http://bio.cse.psu.edu). CpG content analysis was per-
formed by CPGPLOT, which uses the following criteria
for CpG island identification (30): (i) observed/expect-
ed CpG > 0.6; (ii) % (C+G) > 50; and (iii) length > 200 bp.
Results
The centromeric boundary of the genetic interval for AD-
PHP-Ib has been previously defined at marker D20S149
(22, 23). Analysis of genomic DNA from a previously
unstudied child in kindred W (23), W-III/12, revealed a
loss of methylation at GNAS exon A/B (data not shown).
This finding made the recombination event in her moth-
er (W-II/9) informative, thereby redefining the cen-
tromeric boundary of the AD-PHP-Ib locus at marker 907-
Rep2 (Figure 2). Thus the critical interval was reduced to
approximately 280 kb, which included STX16, the gene
encoding syntaxin-16 (31, 32); two predicted genes,
Figure 2
The AD-PHP-Ib critical interval. The AD-PHP-Ib genetic interval was determined by
recombination events in kindreds W (centromeric [cen]) and F (telomeric [tel]). Bound-
ary markers are underlined; microsatellites are in italics. While the distance between
907-Rep2 and 806M20-119516 is about 300 kb, the region between 806M20-98760
and 806M20-119516 has been previously excluded through direct sequence analysis
(23). Thus, the critical interval comprises approximately 280 kb. Note that 261P9-CA1
is a dinucleotide repeat located within intron 6 of STX16. Known and predicted genes
within the linked interval are depicted as filled or open boxes, respectively (note that
individual exons are not shown). For GNAS, exons are shown with black (sense) and
gray (antisense) boxes (N, exon NESP55; A, exons encoding an antisense transcript; X,
exon XL; A/B, exon A/B; 1–13, exons encoding Gsα). MGC4294 (National Center for
Biotechnology Information locus ID: 79160) and NPEPL1 (locus ID: 79716) are pre-
dicted genes. Note that the centromeric boundary of the AD-PHP-Ib locus was previ-
ously defined at D20S149 (22, 23). However, the daughter of W-II/9 in kindred W (23)
was shown to have a loss of exon A/B methylation, making the recombination event in
W-II/9 informative, which redefined the centromeric boundary at 907-Rep2.
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MGC4294 and NPEPL1; and a small centromeric portion
of GNAS. To search for a mutation within this region, a
cosmid library was constructed using genomic DNA from
F-III/37, an affected individual of kindred F (22). For
determining the parental origin of isolated cosmids, novel
and known polymorphic markers that would be inform-
ative for this individual were identified. Dur-
ing the course of these studies, an allelic loss
was detected at marker 261P9-CA1 in affected
individuals and unaffected obligate disease-
gene carriers of kindred F (data not shown). A
391-bp sequence just telomeric of 261P9-CA1
was, with the exception of two base pairs,
directly repeated 2,978 bp (based on
AL139349) further centromeric (Figure 3a).
The allelic loss, in combination with these
direct repeats, suggested the presence of a het-
erozygous disease-associated microdeletion,
which was confirmed by Southern blot analy-
ses using genomic DNA digested with either
AvrII or ClaI (Figure 3b). Wild-type and
mutant alleles could also be amplified by
PCR, thus allowing confirmation of the dele-
tion and providing a simple assay for muta-
tion detection (Figure 3c). Sequence analysis
of the mutant 1.3-kb PCR product showed
that one of the two repeats and the interven-
ing nucleotides were deleted, thus removing a
3-kb region including STX16 exons 4, 5, and 6
(see Figure 3a).
Identical heterozygous microdeletions
were also identified in affected members and
obligate carriers, but not in the healthy mem-
bers, of 11 additional unrelated AD-PHP-Ib
kindreds that show loss of A/B methylation
and no abnormalities at other differentially methylated
regions (DMRs) of GNAS (Table 2). These 11 kindreds,
who reside in several different countries and are of dif-
ferent ethnic and racial backgrounds, included seven
previously published familial cases (22, 23, 25) and four
recently identified kindreds with at least three affected
Figure 3
Identification of the 3-kb microdeletion in kindred F. (a) Genom-
ic structure of the region surrounding the microdeletion. Filled
boxes and connecting lines depict STX16 exons and introns,
respectively. Horizontal bars represent the probes used in South-
ern blot analysis. Arrowheads indicate the location of the two 391-
bp direct repeats (nucleotides 3,786–4,176 and nucleotides
6,764–7,154 of AL139349). Arrows indicate the approximate
positions of the PCR primers used for amplification of the wild-
type and mutant alleles. (b) Southern blot analysis of genomic
DNA from selected members of kindred F (22). Affected individu-
als, filled symbols and bold identification numbers. Healthy indi-
viduals, open symbols and plain numbers. Unaffected obligate
gene carrier, gray circles and bold italic numbers. Genomic DNA
digested with either AvrII (top) or ClaI (bottom) was separated on
0.8% agarose and transferred onto nitrocellulose before hybridiza-
tion with the radiolabeled probe. (c) PCR amplification of the
wild-type (∼4.3 kb) and mutant (∼1.3 kb) alleles from genomic
DNA of members of kindred F (22). Nucleotide sequence analysis
of the 1.3-kb PCR product derived from the mutant allele revealed
that 2,978 bp were deleted (based on AL139349 sequence),
although this number varies due to polymorphisms including the
dinucleotide repeat polymorphism 261P9-CA1 (see Supplemental
Table 1; www.jci.org/cgi/content/full/112/8/1255/DC1).
Table 2
Epigenetic and genetic characteristics of the investigated PHP-Ib kindreds
KindredA Loss of A/B Methylation 3-kb Parental Reference
methylation defects at deletion origin of 
other GNAS deletion 
DMRs in patients
F + – + Mat 22, 23
P + – + Mat 22
D + – + Mat 22
T1 + – + Mat 22
S1 + – + Mat 23
Y1 + – + Mat 23
E + – + Mat 23, 25
A + – + Mat 25
T2 + – + Mat This reportB
I + – + Mat This reportB
K + – + Mat This reportB
H1 + – + ND This reportB
H2C + – + Mat This reportB
T3C + – + Mat This reportB
BC + – + ND 25
H3C + – + ND This reportB
W + – – NA 23
Y2 + + – NA 23
The index cases in families E, A, and B were previously reported as patients 1, 2, and 8,
respectively (25). ANote that these unrelated kindreds were from different countries and dif-
ferent ethnic and racial backgrounds. BBiochemical features of the index cases of new kin-
dreds reported in this study are given in Table 1. CThese were apparently sporadic PHP-Ib
cases, as there were no additional affected family members. Mat, maternal; ND, not
determined due to unavailability of parental DNA samples.
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individuals. For each affected individual, the microdele-
tion was inherited from the mother, which is consistent
with the maternal-specific inheritance of PTH resistance
in AD-PHP-Ib (22, 23). Genomic DNA from 115 healthy
controls, which included unrelated spouses from each
kindred, did not have the microdeletion, as determined
by PCR. The 4.3-kb wild-type product could be amplified
from each sample, whereas the 1.3-kb mutant PCR
product could not be amplified from any of the samples
(data not shown). Taken together, these findings indi-
cated a strong genetic association between AD-PHP-Ib
and the identified mutation.
We also screened 16 apparently sporadic PHP-Ib cases.
Four of the cases, who showed loss of exon A/B methy-
lation only, had the same microdeletion identified in
AD-PHP-Ib kindreds (see Table 2). Analysis of parental
DNA samples, which were available for two of the four
cases with the deletion, showed that the mutations were
inherited from the mothers, who were clinically and
biochemically unaffected. These two patients thus rep-
resented previously unrecognized familial cases.
In contrast with these findings, the 3-kb microdele-
tion was not found in kindreds Y2 and W, in whom
genetic analyses and the mode of inheritance did not
argue against linkage to the GNAS locus (23). While kin-
dred Y2 showed a broad methylation abnormality
involving multiple DMRs of GNAS, kindred W exhibit-
ed a loss-of-methylation defect only at exon A/B and
was therefore investigated further. However, direct
sequence analysis of genomic DNA from affected indi-
vidual W-III/12 excluded a heterozygous small deletion
or a point mutation within the 3-kb region, along with
mutations in the remaining coding STX16 exons (data
not shown). Likewise, analysis of genomic DNA from
the 12 sporadic PHP-Ib cases who were found to exhib-
it epigenetic defects involving not only exon A/B but
also exons NESP55 and XL did not have the 3-kb
microdeletion. Furthermore, nucleotide sequence analy-
ses of these individuals revealed a total of 18 polymor-
phisms but did not identify any smaller deletions or
point mutations within the 3-kb region that is deleted
in most AD-PHP-Ib kindreds (see Supplemental Table 1;
www.jci.org/cgi/content/full/112/8/1255/DC1).
The deleted region is flanked by two direct repeats and
includes three exons of STX16. Note that the 391-bp
repeats differ by two nucleotides: nucleotides 3,959 and
4,147 in the first repeat are cytosine nucleotides, while
the corresponding nucleotides in the second repeat
(nucleotides 6,937 and 7,125) are thymidine nucleotides.
However, nucleotide 3,959 is polymorphic and can be
either cytosine or thymidine. The repeat remaining in
the mutant allele had a thymidine at this position in 14
of the 16 cases with the microdeletion. All 16 had thymi-
dine nucleotides at the other (telomeric) site.
Comparison of the nucleotide sequence with the
regions of conserved synteny in mouse and rat
genomes indicate that the deleted exons of STX16 are
well conserved and that the introns are similar in
length (Figure 4). In addition, there are a number of
conserved intronic sequences, including a stretch of 98
bp located within intron 4. The direct repeats, on the
other hand, are not present in mouse and rat. Based on
analysis of the nucleotide content within the deleted
region, guanine and cytosine nucleotides comprise
43% of the entire sequence, and the overall CpG dinu-
cleotide content is 1.4%. No CpG islands are present in
the deleted region, but a small cluster of CpG dinu-
cleotides is located within STX16 exon 4 (see Figure 4).
To determine whether this region was subject to dif-
ferential methylation, we investigated the methylation
status of CpG dinucleotides in this cluster through
analysis of bisulfite-treated leukocyte DNA. This
analysis revealed that both parental alleles were methy-
lated, indicating the absence of differential methyla-
tion (data not shown).
Figure 4
Genomic structure of the human chromosomal region containing the
AD-PHP-Ib microdeletion. The illustrated region, extending from
nucleotides 3,600 to 7,600 of AL139349, contains STX16 exons 4–6
(black boxes), which are flanked by almost-identical 391-bp direct
repeats (gray boxes); note that only two nucleotides differ between
the two repeat sequences and that nucleotide 3,959 is a polymorphic
C/T (see Supplemental Table 1; www.jci.org/cgi/content/full/112/
8/1255/DC1). The approximate location of the dinucleotide repeat
marker 261P9-CA1 is indicated. Horizontal bars represent uninter-
rupted sequence stretches showing more than 50% identity between
human and mouse or human and rat. Note that the longest stretch
of nucleotide sequence conservation, besides STX16 exons 4–6, is
observed in a 98-bp segment located within intron 4 (nucleotides
5,460–5,557 of AL139349). Dot blots confirmed the location of this
segment in intron 4 of mouse and rat Stx16 (not shown); sequences
homologous to this region could not be found in GenBank. The 391-
bp repeats are not present in the corresponding regions of mouse
and rat genomes. No CpG islands are found in the deleted region.
However, a 140-bp segment within exon 4 (white box; nucleotides
4,572–4,711 of AL139349) has an observed/expected (Obs/Exp)
CpG > 0.6 and % (C + G) > 50; note that the corresponding regions
in mouse and rat do not meet these criteria. Bisulfite PCR analysis
indicated that all 15 CpG dinucleotides in this region were methy-
lated (asterisks) on the maternal (m) and paternal (p) alleles, i.e.,
there was no evidence for differential, parent-specific methylation.
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Discussion
Through analysis of informative markers within the
AD-PHP-Ib critical interval, we detected an allelic loss
in affected individuals and unaffected obligate carriers
of kindred F, the largest AD-PHP-Ib kindred that
defined the telomeric boundary of the genetic locus.
This finding led to the identification of a heterozygous
microdeletion of approximately 3 kb located approxi-
mately 220 kb centromeric of GNAS exon A/B. The
same mutation was also found in each of the affected
members and unaffected carriers of 11 additional kin-
dreds, in whom the epigenetic abnormality in the
affected individuals is limited to the exon A/B DMR.
Thus, all but one of our familial cases who show loss of
exon A/B methylation and no abnormalities at other
GNAS DMRs carry the 3-kb microdeletion. Further-
more, four PHP-Ib patients who were initially thought
to represent sporadic cases were also shown to carry the
same mutation. Consistent with this finding, epige-
netic abnormalities in these patients were limited to
exon A/B. In two of these cases, we determined that the
deletion was inherited from the unaffected mother. On
the other hand, none of the sporadic or familial PHP-
Ib patients demonstrating broad GNAS methylation
abnormalities were found to have the 3-kb microdele-
tion. It thus appears that the identified microdeletion
is specific for and frequently found (16 of 17 cases) in
those PHP-Ib individuals who show an imprinted auto-
somal dominant mode of inheritance
(i.e., AD-PHP-Ib) and a methylation
defect limited to exon A/B.
The heterozygous deletion removes
three of the eight exons encoding syn-
taxin-16, a ubiquitously expressed mem-
ber of the syntaxin family of SNARE pro-
teins (31, 32). Syntaxin-16 is localized
mainly in the Golgi apparatus in the cell,
where it is thought to be involved in
intracellular trafficking (31, 32). Although
the AD-PHP-Ib mutation is predicted to
result in a nonfunctional protein with an
in-frame deletion of 133 amino acids,
syntaxin-16 haploinsufficiency appears
unlikely to explain the loss of exon A/B
methylation and PTH resistance in AD-
PHP-Ib. First, individuals who inherited
the disrupted copy of STX16 paternally,
i.e., unaffected obligate carriers, exhibit
proper GNAS methylation and are clini-
cally and biochemically normal. Second,
renal PTH resistance can develop despite
the presence of two intact copies of STX16,
as shown in a patient with paternal uni-
parental isodisomy of 20q (28). More-
over, there are no reports suggesting that
STX16 is imprinted, and we could not
find any evidence of differential methy-
lation within the CpG island that con-
tains the putative promoter of this gene
(data not shown). Thus, involvement of STX16 and/or
its protein product in the molecular pathogenesis of
AD-PHP-Ib appears unlikely, although oogenesis-spe-
cific mechanisms could be postulated.
Instead, based on the nature of the epigenetic defect
observed in patients carrying the 3-kb microdeletion, we
propose that the deletion disrupts a long-range cis-acting
element regulating methylation of GNAS exon A/B (Fig-
ure 5). Methylation of exon A/B and its promoter is estab-
lished in the female germline and maintained on the
maternal allele through pre- and postimplantation devel-
opment and is thus considered to represent an “imprint
mark” (10). In contrast, it has not been clearly determined
whether differential methylation of the promoters of
NESP55, XLαs, and AS transcripts are also established
during gametogenesis (10). It is therefore possible that
the cis-acting element disrupted by the deletion identified
in AD-PHP-Ib is involved in the establishment and/or
maintenance of the exon A/B imprint in the female
germline rather than its maintenance in somatic cells. For
example, this element could be required for proper inter-
action between the exon A/B region and one or more
DNA methyltransferases in the female germline. Further
investigations are thus required to determine the role of
the deleted region in regulating exon A/B methylation.
Imprinting control elements that show long-range
effects have been defined for other imprinted loci in
human and mouse (33), and microdeletions disrupting
Figure 5
Possible molecular mechanism underlying the marked loss of Gsα expression in the
renal proximal tubule in AD-PHP-Ib. Maternal inheritance of the microdeletion is
associated with loss of methylation at exon A/B and no epigenetic abnormalities at
the NESP55 and XL DMRs, while paternal inheritance of the same deletion is not
associated with methylation defects. We thus postulate that the identified microdele-
tion, which includes STX16 exons 4–6, disrupts a putative cis-acting element regulat-
ing the exon A/B methylation imprint. It has been suggested that in the renal proxi-
mal tubules, a lack of exon A/B methylation and/or active transcription of A/B
mRNA, both of which are normally seen on the paternal GNAS allele, mediate, in cis,
the silencing of Gsα transcription (24). Therefore, the maternal loss of exon A/B
methylation in AD-PHP-Ib is predicted to cause a marked reduction in Gsα expres-
sion levels in that tissue, thereby leading to resistance to PTH (and perhaps to other
hormones), whose action is mediated by the PTH/PTHrP receptor, a predominantly
Gsα-coupled receptor (43). Black and gray boxes depict exons of STX16 and GNAS
in the sense or antisense direction, respectively. White boxes, NPEPL1; asterisks, CpG
methylation; arrows, direction of active transcription.
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these regulatory elements have been identified in
human disorders other than AD-PHP-Ib (34, 35).
Unlike most imprinting control elements, the deleted
region in AD-PHP-Ib has a low CpG content and shows
no evidence for differential methylation (see Figure 4).
However, based on these features, it resembles the
imprinting center disrupted in certain patients with
Angelman syndrome (36–38). While no sequence
homology could be found between the deleted regions
in Angelman syndrome and AD-PHP-Ib, some of the
evolutionarily conserved intronic sequences in the
region deleted in AD-PHP-Ib may represent regulatory
elements required for exon A/B methylation.
The two direct repeats flanking the AD-PHP-Ib
microdeletion consist of AT-rich, MIR, and MER46A
interspersed repeat elements, as well as intervening
unique sequences, and do not seem to be repeated as a
whole elsewhere in the genome. Repetitive DNA
sequences have been located near deletion breakpoints
in other inherited disorders. While highly repetitive Alu
elements appear to be most commonly involved in these
deletions (39), low-copy repeats that flank disease-asso-
ciated deletions have also been reported in certain dis-
orders, such as DiGeorge syndrome (40) and Prader-
Willi/Angelman syndrome (41). As suggested previously
for these other disorders, a mechanism involving homol-
ogous recombination between the flanking repeats may
have led to the deletion in AD-PHP-Ib founders. A dele-
tion generated through such a mechanism is predicted
to occur more frequently than other types of mutations
(such as random genomic rearrangements and single
nucleotide changes), indicating a preferred mechanism
for causing a mutation. This prediction suggests that the
3-kb microdeletion has arisen independently in each kin-
dred. Consistent with this hypothesis, we found the
mutation to be associated in different AD-PHP-Ib kin-
dreds with different alleles of a C/T SNP (261P9-15,686;
see Figure 2) located approximately 10 kb to the telom-
ere (C in two kindreds and T in eight kindreds), strong-
ly suggesting that it has occurred on at least two differ-
ent haplotype backgrounds. This hypothesis is further
supported by having the 3-kb microdeletion in multiple
kindreds of divergent ethnic and racial backgrounds. In
fact, the microdeletion was the only mutation identified
in our collection of PHP-Ib patients, which is consistent
with the predicted high frequency of this type of muta-
tion. Nevertheless, investigation of additional patients
may reveal other mutations within the deleted region or
in adjacent DNA sequences, and these may help delin-
eate more precisely the putative regulatory element
involved in the molecular pathogenesis of AD-PHP-Ib
and possibly other forms of PHP-Ib.
Two of the previously published PHP-Ib kindreds
with an apparent autosomal trait did not carry the 3-
kb microdeletion (see Table 2). Kindred Y2 has broad
epigenetic abnormalities affecting several DMRs of
GNAS (23), and therefore the absence of the identified
microdeletion in this kindred was not entirely unex-
pected. For kindred W, however, the epigenetic
changes are indistinguishable from those observed in
other families with AD-PHP-Ib (23). Furthermore,
two-point lod scores for markers in this region strong-
ly suggest that the genetic defect in kindred W is locat-
ed close to GNAS (lod score of 2.5 at D20S171 [θ = 0],
which is identical to the maximal theoretical lod
score). However, affected individuals of this kindred
do not have other mutations within the 3-kb region
that is deleted in most AD-PHP-Ib kindreds, or muta-
tions in the remaining coding STX16 exons (data not
shown). It thus appears likely that methylation of exon
A/B requires an additional cis-acting element that is
mutated in kindred W.
We observed methylation abnormalities at multiple
GNAS DMRs in 12 sporadic cases, as well as in two
PHP-Ib kindreds with multiple affected individuals
other than kindred Y2 (M. Bastepe and H. Jüppner,
unpublished observations). Owing to the small num-
ber of DNA samples currently available, linkage of the
genetic defect in these kindreds to the previously estab-
lished AD-PHP-Ib locus has not been confirmed. How-
ever, already available genetic data do not argue against
linkage to GNAS. Furthermore, at least for kindred Y2,
methylation of a distinct DMR on chromosome 20q
that involves NNAT, the gene encoding neuronatin
(42), is preserved (23). These findings suggest that the
genetic defect in this kindred, and perhaps in other
sporadic or familial forms of PHP-Ib with broad GNAS
methylation abnormalities, also resides in proximity to
GNAS. Hence, there may be yet another putative cis-act-
ing element involved in regulating methylation at all
DMRs of this gene, rather than exon A/B alone.
In summary, we have identified a microdeletion asso-
ciated with AD-PHP-Ib in multiple kindreds. The
microdeletion is located within STX16 approximately
220-kb centromeric of GNAS exon A/B, i.e., upstream of
the DMR at which AD-PHP-Ib patients show loss of
methylation. Additional investigations will be necessary
to elucidate the molecular mechanisms resulting in the
epigenetic and biochemical abnormalities observed in
AD-PHP-Ib and its variants. Insights from these studies
will not only clarify the different biological roles of
GNAS, but are also likely to enhance our understanding
of other imprinted genes. Furthermore, new informa-
tion may be gained regarding the tissue- and cell-specif-
ic silencing of the ubiquitously expressed Gsα, and such
studies could lead to the discovery of additional mecha-
nisms that may help explain Gsα-dependent end-organ
responsiveness to a large variety of different hormones.
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